Literature DB >> 22872307

Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.

David Garcia-Garcia1, Pedro Clavero, Carmen Gasca Salas, Isabel Lamet, Javier Arbizu, Rafael Gonzalez-Redondo, Jose A Obeso, Maria C Rodriguez-Oroz.   

Abstract

PURPOSE: Patients with Parkinson's disease (PD) may have normal cognition, mild cognitive impairment (MCI) or dementia. We investigated differences in cerebral metabolism associated with these three cognitive states and the relationship between metabolism and cognitive dysfunction.
METHODS: FDG PET and a battery of neuropsychological tests were used to study PD patients with dementia (n = 19), MCI (n = 28) and normal cognition (n = 21), and control subjects (n = 20). Regional glucose metabolism in patients and controls was analysed using statistical parametric mapping (SPM8) corrected for age, motor severity and depression. Correlations between the mini-mental state examination score and Z-score values of the different cognitive domains with respect to cerebral FDG uptake were assessed using SPM8.
RESULTS: PD patients with MCI (PD-MCI patients) exhibited decreased FDG uptake in the frontal lobe, and to a lesser extent in parietal areas compared with cognitively normal patients. Patients with dementia showed reduced metabolism in the parietal, occipital and temporal areas and a less extensive reduction in the frontal lobe compared with PD-MCI patients, while widespread hypometabolism was seen in comparison with patients with normal cognition. PD-MCI patients exhibited reduced FDG uptake in the parietal and occipital lobes and in localized areas of the frontal and temporal lobes compared with controls, whereas patients with dementia showed a widespread reduction of cortical metabolism. Mini-mental state examination score correlated positively with metabolism in several lobes, executive function with metabolism in the parietooccipitotemporal junction and frontal lobe, memory with temporoparietal metabolism, visuospatial function with occipitoparietal and temporal metabolism, and language with frontal metabolism.
CONCLUSION: PD patients with MCI exhibited hypometabolism in several cortical regions compared with controls, and in the frontal and parietal regions compared with cognitively normal patients. Hypometabolism was higher in patients with dementia than in those with MCI, mainly in the posterior cortical areas where it was correlated with visuospatial, memory and executive functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872307     DOI: 10.1007/s00259-012-2198-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  53 in total

1.  Collaborative activity between parietal and dorso-lateral prefrontal cortex in dynamic spatial working memory revealed by fMRI.

Authors:  V A Diwadkar; P A Carpenter; M A Just
Journal:  Neuroimage       Date:  2000-07       Impact factor: 6.556

2.  Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

Authors:  Peter Hobson; Jolyon Meara
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

Review 3.  The central executive: a concept and some misconceptions.

Authors:  A Baddeley
Journal:  J Int Neuropsychol Soc       Date:  1998-09       Impact factor: 2.892

Review 4.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

5.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

6.  Grey matter atrophy in cognitively impaired Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-02       Impact factor: 10.154

7.  Executive processes in Parkinson's disease: FDG-PET and network analysis.

Authors:  Catherine Lozza; Jean-Claude Baron; David Eidelberg; Marc J Mentis; Maren Carbon; Rose-Marie Marié
Journal:  Hum Brain Mapp       Date:  2004-07       Impact factor: 5.038

8.  Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.

Authors:  S Minoshima; K A Frey; N L Foster; D E Kuhl
Journal:  J Comput Assist Tomogr       Date:  1995 Jul-Aug       Impact factor: 1.826

9.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Authors:  Thomas Foltynie; Carol E G Brayne; Trevor W Robbins; Roger A Barker
Journal:  Brain       Date:  2003-12-22       Impact factor: 13.501

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more
  37 in total

Review 1.  The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Authors:  María C Rodriguez-Oroz; Belen Gago; Pedro Clavero; Manuel Delgado-Alvarado; David Garcia-Garcia; Haritz Jimenez-Urbieta
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

2.  Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.

Authors:  Arianna Sala; Silvia Paola Caminiti; Leonardo Iaccarino; Luca Beretta; Sandro Iannaccone; Giuseppe Magnani; Alessandro Padovani; Luigi Ferini-Strambi; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2019-07-19       Impact factor: 5.038

3.  Functional impact of subthalamotomy by magnetic resonance-guided focused ultrasound in Parkinson's disease: a hybrid PET/MR study of resting-state brain metabolism.

Authors:  Rafael Rodriguez-Rojas; Jose A Pineda-Pardo; Raul Martinez-Fernandez; Rosalie V Kogan; Carlos A Sanchez-Catasus; Marta Del Alamo; Frida Hernández; Lina García-Cañamaque; Klaus L Leenders; Jose A Obeso
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-08       Impact factor: 9.236

4.  Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.

Authors:  Daniella Balduino Victorino; Mariana Nejm; Marcia Guimarães-Marques; Fulvio Alexandre Scorza; Carla Alessandra Scorza
Journal:  Pharmaceut Med       Date:  2021-01-07

5.  Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.

Authors:  Rafael González-Redondo; David García-García; Pedro Clavero; Carmen Gasca-Salas; Reyes García-Eulate; José L Zubieta; Javier Arbizu; José A Obeso; María C Rodríguez-Oroz
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

Review 6.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

7.  Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson's disease.

Authors:  Zoe Joanna Syrimi; Lubomir Vojtisek; Ilona Eliasova; Jana Viskova; Alena Svatkova; Jiri Vanicek; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-03-07       Impact factor: 3.575

8.  Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.

Authors:  Campbell J Le Heron; Sarah L Wright; Tracy R Melzer; Daniel J Myall; Michael R MacAskill; Leslie Livingston; Ross J Keenan; Richard Watts; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-12       Impact factor: 6.200

9.  Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Jia Y Wan; Thomas J Montine; Joseph F Quinn; Ignacio F Mata; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; James B Leverenz; Karen L Edwards
Journal:  Mov Disord       Date:  2014-04-07       Impact factor: 10.338

10.  Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study.

Authors:  Sanne K Meles; Chris C Tang; Laura K Teune; Rudi A Dierckx; Vijay Dhawan; Paul J Mattis; Klaus L Leenders; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.